Evaluation of Sex Hormones in the Treatment of Benign Prostatic Hypertrophy, Carcinoma of the Prostate and Other Diseases of the Genito-Urinary System1

Publisher Website
Google Scholar
Abstract
The use of sex hormones for treatment of genito-urinary diseases is discussed. Clinical data are presented to substantiate the following conclusions. About 50% of patients with advanced prostatic cancer are greatly improved by estrogenic therapy. The time elapsed since treatment is yet too short to evaluate end results. The treatment of prostatic hypertrophy (associated with bladder insufficiency) is still a surgical procedure, even though the adm. of estrogens to such patients produces extensive temporary alterations in the glandular structure of the prostate. There should be a thorough search for the causes of impotence and other sex disorders before a course of hormonal therapy is given.

This publication has 1 reference indexed in Scilit: